S2676
RTT - Patient experience and quality of life
ESTRO 2026
support from Macmillan, clinicians and patient advocates, a year ago we launched a radiographer-led service for people with radiotherapy late-effects and here present the impact of the service. Material/Methods: People can self-refer, or be referred from their primary care team, treating oncology team, or allied health professionals. All referrals to the service are recorded in a centralised database, with baseline demographic and clinical data. All are discussed in multidisciplinary team meeting, consisting of three radiographers, a navigator and two consultant medics (gastroenterologist and oncologist), and outcomes fed back to the referrer. Appointments are offered face to face predominantly, in one of three sites, but also virtual if travel is a barrier. Results: Since its launch in September 2024, the service has had 143 referrals; 102 from healthcare professionals and 41 self-referrals. The majority referred were aged over 60 (57%), but there was a substantial range, with 23% referred aged under 40. Forty-one percent of people referred had been treated for prostate cancer, 20% for gynaecological malignancies, 18% for breast cancer, and 8% for head and neck cancer. Time since completion of treatment ranged from six months to 11 years (mean 28 months). The majority of patients were managed by the radiographers, with only two patients requiring joint review with the consultant oncologist. Aside from blood and stool tests, the commonest intervention required was lower GI endoscopy. Seventy percent of patients reported an increased health-related quality of life following review, measured using the EQ-5D index. Patients valued having time to discuss symptoms and receive clear explanations of radiotherapy late-effects. Conclusion: Our model of a radiographer-led non-tumour site specific late-effects service is feasible and results in a significant increase in patients' health-related quality of life. Detailed cost-effectiveness analyses are ongoing, but onward referral is rare, suggesting the model is likely to reduce cost compared to consultant- led services. The nature of our team and pre-existing services mean that the majority of people referred have gastrointestinal late-effects, but our aim is to encourage referrals from other groups and strengthen relationships with primary care and community groups to ensure equal access for all those treated with radiotherapy. Keywords: Late-effects, patient experience, quality of life
ensure applicability to RTTs when caring for TNBI patients.The first UK national radiotherapy consent forms were implemented in May 2021 [3]. In August 2022, the network reached out to the body leading on these to make these forms inclusive to the LGBTQI+ community. They were updated collaboratively and implemented in 2023. Conclusion: The network has demonstrated the value of a coordinated professional group in advancing inclusive practice for LGBTQI+ patients. By engaging proactively with national bodies, responding constructively to public discourse and contributing to policy development, the group has shown how RTTs can directly influence patient care, communication standards, and equality within radiation services. Its work highlights the importance of professional collaboration and advocacy in overcoming barriers to truly inclusive radiotherapy practice. References: [1] IR(ME)R (2017). The Ionising Radiation (Medical Exposure) Regulations 2017. [online] Legislation.gov.uk. Available at: https://www.legislation.gov.uk/uksi/2017/1322/[2] for (2024). Inclusive pregnancy status guidelines for ionising radiation: Diagnostic and therapeutic exposures | SoR. [online] SoR. Available at: https://www.sor.org/learning-advice/Professional- body-guidance-and-publications/Documents-and- publications/Policy-Guidance-Document- Library/Inclusive-pregnancy-status-guidelines-for-ioni- (1)[3] www.rcr.ac.uk. (n.d.). National radiotherapy consent forms | The Royal College of Radiologists. [online] Available at: https://www.rcr.ac.uk/our- services/management-service-delivery/national- radiotherapy-consent-forms/ Keywords: LGBTQI+, Inclusive, Network Mini-Oral 3633 One year on: Building a Macmillan radiotherapy late-effects service Rebecca Shakir, Courtney Faria Simas, Mitch Sharman- Else, Sinead Sullivan, Marios Spindler, Luke Timbrell, Jan Bornschein Deparment of Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom Purpose/Objective: Radiotherapy remains a cornerstone of cancer treatment. Despite advanced techniques aimed at sparing normal tissues, there remains a substantial risk of late-effects in people treated curatively with radiotherapy. Ongoing care for people with late-effects is variable, and they can be caught in a repeated loop of appointments and unanswered questions. With
Mini-Oral 3781
Made with FlippingBook - Share PDF online